Kailera Clinical Site

Greensboro, North Carolina 27405

1 studies enrolling now · 2 studies all time

What they study most

Obesity, Obesity With Diabetes, Overweight With Diabetes

Studies at this site

• Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes — Recruiting now
• Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes — Running, not enrolling